Breast Cancer Monoclonal Antibodies Market 2024-2028
Incremental Growth2024-2028 (US$bn)
$ 19.2
2024 Year-over-Year Growth
12.02%
CAGR (2024-2028)
13.97%
Report Coverage
Global
Breast Cancer Monoclonal Antibodies Market Segmentation
Market Segmentation & Scope
Market Segment by Geographic Landscape
41%
of the growth will originate
from North America
Global Market Size 2018 - 2028 (US$ Bn)
Market is segmented by End-user into Hospitals, Research institutes, Others
The Hospitals is expected to be largest growing segment during 2024-2028Largest Segment - Hospitals
US$ 35.60 Bn
Breast Cancer Monoclonal Antibodies Market by End-user into Hospitals; 2018-2028 (US$ Bn)
Hospitals Market Revenue and Forecast 2018-2028 (US$ Bn)Hospitals
- Hospitals Market Size and Forecast 2018 to 2028 (US$ Bn)
Breast Cancer Monoclonal Antibodies Market by End-user into Research institutes; 2018-2028 (US$ Bn)
Research institutes Market Revenue and Forecast 2018-2028 (US$ Bn)Research institutes
- Research institutes Market Size and Forecast 2018 to 2028 (US$ Bn)
Breast Cancer Monoclonal Antibodies Market by End-user into Others; 2018-2028 (US$ Bn)
Others Market Revenue and Forecast 2018-2028 (US$ Bn)Others
- Others Market Size and Forecast 2018 to 2028 (US$ Bn)
Market is segmented by Type into Humanized, Human, Chimeric, Murine
The Humanized is expected to be largest growing segment during 2024-2028Largest Segment - Humanized
US$ 34.00 Bn
Breast Cancer Monoclonal Antibodies Market Size by Segmentation, by Type (US$ Bn)
Type | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | CAGR (%) |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Humanized | 6.00 | XX | XX | XX | XX | XX | XX | XX | XX | XX | XX | XX |
Human | XX | 5.30 | XX | XX | XX | XX | XX | XX | XX | XX | XX | XX |
Chimeric | XX | XX | 2.30 | XX | XX | XX | XX | XX | XX | XX | XX | XX |
Murine | XX | XX | XX | 1.60 | 1.70 | XX | XX | XX | XX | XX | XX | XX |
Breast Cancer Monoclonal Antibodies Market by Type into Humanized; 2018-2028 (US$ Bn)
Humanized Market Revenue and Forecast 2018-2028 (US$ Bn)Humanized
- Humanized Market Size and Forecast 2018 to 2028 (US$ Bn)
Breast Cancer Monoclonal Antibodies Market by Type into Human; 2018-2028 (US$ Bn)
Human Market Revenue and Forecast 2018-2028 (US$ Bn)Human
- Human Market Size and Forecast 2018 to 2028 (US$ Bn)
Breast Cancer Monoclonal Antibodies Market by Type into Chimeric; 2018-2028 (US$ Bn)
Chimeric Market Revenue and Forecast 2018-2028 (US$ Bn)Chimeric
- Chimeric Market Size and Forecast 2018 to 2028 (US$ Bn)
Breast Cancer Monoclonal Antibodies Market by Type into Murine; 2018-2028 (US$ Bn)
Murine Market Revenue and Forecast 2018-2028 (US$ Bn)Murine
- Murine Market Size and Forecast 2018 to 2028 (US$ Bn)
Market is segmented by Geography into North America, Europe, Asia, ROW
The North America is estimated to contribute 41% to the growth of global market during the forecast period 2024-2028.Largest Segment - North America
41%
Regional share of different regions, including North America, Europe, Asia, Rest of World (ROW)
Region | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | CAGR (%) |
---|---|---|---|---|---|---|---|---|---|---|---|---|
North America | 5.90 | XX | XX | XX | XX | XX | XX | XX | XX | XX | XX | XX |
Europe | XX | 4.50 | XX | XX | XX | XX | XX | XX | XX | XX | XX | XX |
Asia | XX | XX | 2.90 | XX | XX | XX | XX | XX | XX | XX | XX | XX |
ROW | XX | XX | XX | 1.70 | 1.90 | XX | XX | XX | XX | XX | XX | XX |
Breast Cancer Monoclonal Antibodies Market Size by Geography into North America; 2018-2028 (US$ Bn)
North America Market Revenue and Forecast 2018-2028 (US$ Bn)Breast Cancer Monoclonal Antibodies Market Size by Country into Canada; 2018-2028 (US$ Bn)
Canada Market Revenue and Forecast 2018-2028 (US$ Bn)Breast Cancer Monoclonal Antibodies Market Size by Country into US; 2018-2028 (US$ Bn)
US Market Revenue and Forecast 2018-2028 (US$ Bn)Breast Cancer Monoclonal Antibodies Market Size by Geography into Europe; 2018-2028 (US$ Bn)
Europe Market Revenue and Forecast 2018-2028 (US$ Bn)Breast Cancer Monoclonal Antibodies Market Size by Country into France; 2018-2028 (US$ Bn)
France Market Revenue and Forecast 2018-2028 (US$ Bn)Breast Cancer Monoclonal Antibodies Market Size by Geography into Asia; 2018-2028 (US$ Bn)
Asia Market Revenue and Forecast 2018-2028 (US$ Bn)Breast Cancer Monoclonal Antibodies Market Size by Country into China; 2018-2028 (US$ Bn)
China Market Revenue and Forecast 2018-2028 (US$ Bn)Breast Cancer Monoclonal Antibodies Market Size by Geography into ROW; 2018-2028 (US$ Bn)
ROW Market Revenue and Forecast 2018-2028 (US$ Bn)Major Companies
Market Companies
Name | Profile | Employees | Headquarters | Website | |
---|---|---|---|---|---|
Amgen Inc. | View Profile | 101-250 | Santa Clara, California, United States, North America | avinetworks.com | |
AstraZeneca Plc | View Profile | 101-250 | Santa Clara, California, United States, North America | avinetworks.com | |
Boehringer Ingelheim International GmbH | View Profile | 101-250 | Santa Clara, California, United States, North America | avinetworks.com | |
Bristol Myers Squibb Co. | View Profile | 101-250 | Santa Clara, California, United States, North America | avinetworks.com | |
Celldex Therapeutics Inc | View Profile | 101-250 | Santa Clara, California, United States, North America | avinetworks.com | |
Celltrion Co. Ltd. | View Profile | 101-250 | Santa Clara, California, United States, North America | avinetworks.com | |
Daiichi Sankyo Co. Ltd. | View Profile | 101-250 | Santa Clara, California, United States, North America | avinetworks.com | |
Eisai Co. Ltd. | View Profile | 101-250 | Santa Clara, California, United States, North America | avinetworks.com | |
F. Hoffmann La Roche Ltd. | View Profile | 101-250 | Santa Clara, California, United States, North America | avinetworks.com | |
Gilead Sciences Inc. | View Profile | 101-250 | Santa Clara, California, United States, North America | avinetworks.com | |
Johnson and Johnson Services Inc. | View Profile | 101-250 | Santa Clara, California, United States, North America | avinetworks.com | |
MacroGenics Inc. | View Profile | 101-250 | Santa Clara, California, United States, North America | avinetworks.com | |
Merck KGaA | View Profile | 101-250 | Santa Clara, California, United States, North America | avinetworks.com | |
Novartis AG | View Profile | 101-250 | Santa Clara, California, United States, North America | avinetworks.com | |
Pfizer Inc. | View Profile | 101-250 | Santa Clara, California, United States, North America | avinetworks.com | |
Puma Biotechnology Inc. | View Profile | 101-250 | Santa Clara, California, United States, North America | avinetworks.com | |
Sanofi SA | View Profile | 101-250 | Santa Clara, California, United States, North America | avinetworks.com | |
Seagen Inc. | View Profile | 101-250 | Santa Clara, California, United States, North America | avinetworks.com | |
Teva Pharmaceutical Industries Ltd. | View Profile | 101-250 | Santa Clara, California, United States, North America | avinetworks.com | |
Viatris Inc. | View Profile | 101-250 | Santa Clara, California, United States, North America | avinetworks.com |
Breast Cancer Monoclonal Antibodies Market Scope
- By End-user
- Introduction / Key Findings
- Historical Market Size Value (US$ billion) Analysis By End-user, 2017 to 2022
- Current and Future Market Size Value (US$ billion) Analysis and Forecast By End-user, 2024 to 2028
- Y-o-Y Growth Trend Analysis By End-user, 2017 to 2022
- Absolute $ Opportunity Analysis By End-user, 2024 to 2028
- By Type
- Introduction / Key Findings
- Historical Market Size Value (US$ billion) Analysis By Type, 2017 to 2022
- Current and Future Market Size Value (US$ billion) Analysis and Forecast By Type, 2024 to 2028
- Y-o-Y Growth Trend Analysis By Type, 2017 to 2022
- Absolute $ Opportunity Analysis By Type, 2024 to 2028
- By Region
- Introduction / Key Findings
- Historical Market Size Value (US$ billion) Analysis By Region, 2017 to 2022
- Current and Future Market Size Value (US$ billion) Analysis and Forecast By Region, 2024 to 2028
- North America Market Analysis 2017 to 2022 and Forecast 2024 to 2028, By Country
- Historical Market Size Value (US$ billion) Trend Analysis By Market, 2017 to 2022
- Market Size Value (US$ billion) Forecast By Market, 2024 to 2028
- By Country
- By End-user
- By Type
- Europe Market Analysis 2017 to 2022 and Forecast 2024 to 2028, By Country
- Historical Market Size Value (US$ billion) Trend Analysis By Market, 2017 to 2022
- Market Size Value (US$ billion) Forecast By Market, 2024 to 2028
- By Country
- By End-user
- By Type
- Asia Market Analysis 2017 to 2022 and Forecast 2024 to 2028, By Country
- Historical Market Size Value (US$ billion) Trend Analysis By Market, 2017 to 2022
- Market Size Value (US$ billion) Forecast By Market, 2024 to 2028
- By Country
- By End-user
- By Type
- Rest of World (ROW) Market Analysis 2017 to 2022 and Forecast 2024 to 2028, By Country
- Historical Market Size Value (US$ billion) Trend Analysis By Market, 2017 to 2022
- Market Size Value (US$ billion) Forecast By Market, 2024 to 2028
- By End-user
- By Type
Major Companies
Market companies
Name | Profile | Employees | Headquarters | Website | |
---|---|---|---|---|---|
Amgen Inc. | View Profile | 101-250 | Santa Clara, California, United States, North America | avinetworks.com | |
AstraZeneca Plc | View Profile | 101-250 | Santa Clara, California, United States, North America | avinetworks.com | |
Boehringer Ingelheim International GmbH | View Profile | 101-250 | Santa Clara, California, United States, North America | avinetworks.com | |
Bristol Myers Squibb Co. | View Profile | 101-250 | Santa Clara, California, United States, North America | avinetworks.com | |
Celldex Therapeutics Inc | View Profile | 101-250 | Santa Clara, California, United States, North America | avinetworks.com | |
Celltrion Co. Ltd. | View Profile | 101-250 | Santa Clara, California, United States, North America | avinetworks.com | |
Daiichi Sankyo Co. Ltd. | View Profile | 101-250 | Santa Clara, California, United States, North America | avinetworks.com | |
Eisai Co. Ltd. | View Profile | 101-250 | Santa Clara, California, United States, North America | avinetworks.com | |
F. Hoffmann La Roche Ltd. | View Profile | 101-250 | Santa Clara, California, United States, North America | avinetworks.com | |
Gilead Sciences Inc. | View Profile | 101-250 | Santa Clara, California, United States, North America | avinetworks.com | |
Johnson and Johnson Services Inc. | View Profile | 101-250 | Santa Clara, California, United States, North America | avinetworks.com | |
MacroGenics Inc. | View Profile | 101-250 | Santa Clara, California, United States, North America | avinetworks.com | |
Merck KGaA | View Profile | 101-250 | Santa Clara, California, United States, North America | avinetworks.com | |
Novartis AG | View Profile | 101-250 | Santa Clara, California, United States, North America | avinetworks.com | |
Pfizer Inc. | View Profile | 101-250 | Santa Clara, California, United States, North America | avinetworks.com | |
Puma Biotechnology Inc. | View Profile | 101-250 | Santa Clara, California, United States, North America | avinetworks.com | |
Sanofi SA | View Profile | 101-250 | Santa Clara, California, United States, North America | avinetworks.com | |
Seagen Inc. | View Profile | 101-250 | Santa Clara, California, United States, North America | avinetworks.com | |
Teva Pharmaceutical Industries Ltd. | View Profile | 101-250 | Santa Clara, California, United States, North America | avinetworks.com | |
Viatris Inc. | View Profile | 101-250 | Santa Clara, California, United States, North America | avinetworks.com |
Subscribe to World-Class Market Intelligence
Basic Plan
Experience the best of reports & insights